Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Emergent BioSolutions
This is a prospective safety surveillance study in a US military Department of Defense (DoD) population. Military subjects either naive to smallpox immunization and have received ACAM2000® vaccine or who have previously been immunized with a vaccinia vaccine, usually Dryvax®, will be enrolled into the study.
No vaccine will be administered as part of this study.
Age
17–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Written informed consent obtained prior to the conduct of any study-related procedures.
Male and Female military personnel positioned for active deployment.
Participant naïve to previous smallpox vaccination and received the ACAM2000 vaccine (Cohort 1), OR, Participant has not received ACAM2000 vaccine within the prior 3 years, AND is ineligible for current ACAM2000 vaccination either because of recency of prior vaccinia vaccination or for reasons solely attributable to conditions or characteristics of their contacts (such as a healthy soldier who is married to someone with a contraindicated condition) (Cohort 2).
You may not be if
Subjects judged by the investigator as unlikely to understand the scope of the study and/or unlikely to be able to be compliant with the study procedures and visits.
Participation in any other studies involving investigational or marketed products within 30 days prior to Visit 1.